Active

LIEPHARM

Switched

BE0728704778

Rechtspersoon Private limited company 1 establishment

Place Joseph Meunier 11, 5640 Mettet Activiteiten van holdings

Active for

7 year, 2 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 126,790

▼ 1% vs 2024

Profit

Growing

€ 64,975

▲ 2% vs 2024

Debts

High

€ 1.5 million

▲ 5% vs 2024

LIEPHARM from Mettet, company number BE0728704778, closed financial year 2025 with a result of € 64,975 after tax. For that financial year LIEPHARM recorded a gross margin of € 126,790 and equity of € 119,377. Compared with financial year 2024, the result moved from € 63,518 to € 64,975. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What happened at LIEPHARM?

What happened at LIEPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 64,975 (▲ 2% vs 2024). Source: NBB ↗
  • New establishment in Mettet. KBO
  • GENEVIEVE LIENARD became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 94,505 profit in 2021 to € 64,975 profit in 2025.

Paid € 98,385 in corporate taxes since 2021.

Best year ever: 2021, with € 94,505 profit.

Paid out € 360,000 in dividends to the owners in total.

A new publication or filing at LIEPHARM? We notify you, reason included.

Follow LIEPHARM

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

GENEVIEVE LIENARD
LIEPHARM
LIEPHAR 100%

Behind LIEPHARM is GENEVIEVE LIENARD. It owns 100% of LIEPHAR itself.

See the full network in the app

Directors

According to the 2025 annual accounts

GENEVIEVE LIENARD

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Place Joseph Meunier 11

5640 Mettet

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0728.704.778
VAT number
BE 0728.704.778
Registered office
Place Joseph Meunier 11, 5640 Mettet
Names & denominations
LIEPHARM
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
20 June 2019
Peppol
Active · Active since 14 Nov 2025
Activities · NACE

Activiteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of LIEPHARM?
The enterprise number of LIEPHARM is BE0728704778.
What is the address of LIEPHARM?
The registered office of LIEPHARM is located at Place Joseph Meunier 11, 5640 Mettet.
When was LIEPHARM founded?
LIEPHARM was founded on 20 June 2019.
What is the main activity of LIEPHARM?
The main activity of LIEPHARM is "Activiteiten van holdings" (NACE code 64210).
Does LIEPHARM have a website?
No website is currently known for LIEPHARM.
How much profit did LIEPHARM make in 2025?
LIEPHARM posted a profit after taxes of € 64,975 in financial year 2025.
What is the revenue of LIEPHARM?
As a small company, LIEPHARM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 126,790.
Where can I find the annual accounts of LIEPHARM?
LIEPHARM files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of LIEPHARM?
According to the 2025 annual accounts, the directors of LIEPHARM are: GENEVIEVE LIENARD.
Who owns LIEPHARM?
Behind LIEPHARM is GENEVIEVE LIENARD. It owns 100% of LIEPHAR itself.